1
|
Dor C, Gajanayake I, Kortum A, Day MJ, Tappin S, Harris B, Battersby I, Walker D, Glanemann B, Myatt P, Dunning M, Bexfield N. Characterisation and outcome of idiopathic pyogranulomatous lymphadenitis in 64 English springer spaniel dogs. J Small Anim Pract 2019; 60:551-558. [PMID: 31317549 DOI: 10.1111/jsap.13052] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2019] [Revised: 05/01/2019] [Accepted: 06/14/2019] [Indexed: 11/26/2022]
Abstract
OBJECTIVES To describe the history, clinicopathological abnormalities, diagnostic imaging findings, lymph node cytological/histological appearance, treatment and outcome of English springer spaniels diagnosed with idiopathic pyogranulomatous lymphadenitis. MATERIALS AND METHODS In this retrospective UK-based multicentre study, 64 dogs were recruited from 10 referral centres, 32 first-opinion practices and three histopathology/cytology laboratories, between 2010 and 2016. RESULTS The median age at presentation was 6 years (range: 0.17 to 11.75). Neutered females were frequently affected. Pyrexia (83.8%), peripheral lymphadenomegaly (78.4%), dermatological lesions (72.9%), lethargy (67.6%), hyporexia (54%), diarrhoea (29.7%), coughing (24.3%), epistaxis, sneezing or nasal discharge (21.6%), ocular signs (21.6%) and vomiting (16.2%) were reported in dogs for which the history and physical examination records were available. Popliteal (45.3%), superficial cervical (35.9%) and submandibular (37.5%) lymphadenomegaly were frequently reported. Haematology and serum biochemistry revealed non-specific changes. When undertaken, testing for infectious diseases was negative in all cases. Lymph node cytology, histopathology or both demonstrated mixed inflammatory (27%), pyogranulomatous (24%), neutrophilic (20%) or granulomatous (11%) lymphadenitis. Treatment details were available for 38 dogs, with 34 receiving prednisolone for a median duration of 15 weeks (range: 1 to 28 weeks). A good to excellent clinical response was reported in all but one case. Ten dogs relapsed after discontinuing prednisolone. CLINICAL SIGNIFICANCE Idiopathic pyogranulomatous lymphadenitis should be considered as a differential diagnosis for lymphadenopathy and pyrexia in English springer spaniels. The characteristics of the disease, absence of identifiable infectious aetiology and response to glucocorticoid therapy suggest an immune-mediated aetiology.
Collapse
Affiliation(s)
- C Dor
- Department of Veterinary Medicine and Science, University of Nottingham, Nottingham, NG7 2RD, UK
| | - I Gajanayake
- Willows Veterinary Centre and Referral Service, Solihull, West Midlands, B90 4NH, UK
| | - A Kortum
- Department of Veterinary Medicine, University of Cambridge, Cambridge, CB3 0ES, UK
| | - M J Day
- School of Veterinary and Life Sciences, Murdoch University, Murdoch, Western Australia, 6150, Australia
| | - S Tappin
- Dick White Referrals, Six Mile Bottom, Cambridge, CB8 0UH, UK
| | - B Harris
- Northwest Veterinary Specialists, Sutton Weaver, Cheshire, WA7 3FW, UK
| | - I Battersby
- Davies Veterinary Specialists, Hitchin, Hertfordshire, SG5 3HR, UK
| | - D Walker
- Anderson Moores Veterinary Specialists, Hursley, Winchester, SO21 2LL, UK
| | - B Glanemann
- Royal Veterinary College, University of London, London, NW1 0TU, UK
| | - P Myatt
- Department of Veterinary Medicine and Science, University of Nottingham, Nottingham, NG7 2RD, UK
| | - M Dunning
- Department of Veterinary Medicine and Science, University of Nottingham, Nottingham, NG7 2RD, UK.,Willows Veterinary Centre and Referral Service, Solihull, West Midlands, B90 4NH, UK
| | - N Bexfield
- Department of Veterinary Medicine, University of Cambridge, Cambridge, CB3 0ES, UK
| |
Collapse
|
2
|
Abstract
Ciclosporin is a lipophilic cyclic polypeptide with powerful immunosuppressive and immunomodulatory properties that has been used in veterinary medicine for two decades. It is a calcineurin inhibitor whose principal mode of action is to inhibit T cell activation. The drug is principally absorbed from the small intestine and is metabolised in the intestine and liver by the cytochrome P450 enzyme system. Ciclosporin is known to interact with a wide range of pharmacological agents. Numerous studies have demonstrated good efficacy for the management of canine atopic dermatitis and this has been a licensed indication since 2003. In addition to the treatment of atopic dermatitis, it has been used as an aid in the management of numerous other dermatological conditions in animals including perianal fistulation, sebaceous adenitis, pododermatitis, chronic otitis externa and pemphigus foliaceus. This article reviews the mode of action, pharmacokinetics, indications for use and efficacy of ciclosporin in veterinary dermatology.
Collapse
Affiliation(s)
- Peter Forsythe
- The Dermatology Referral Service, 528 Paisley Road West, Glasgow G51 1RN, UK
| | | |
Collapse
|